FOURTEAU PATRICK

CIK 00012356373 companiesCHANDLER, AZ

SEC Profile

Transactions

Companies

Filings

CIK

0001235637

Recent Transactions

50 trades

Disposition to Issuer
REPROS THERAPEUTICS INC.
Common Stock
2018-01-31$0.67/sh−27,779→ 0 total
Disposition to Issuer
REPROS THERAPEUTICS INC.
Stock Option
2018-01-31−5,000→ 0 total
Disposition from Tender
REPROS THERAPEUTICS INC.
Common Stock
2018-01-29$0.67/sh−12,221→ 27,779 total
Award
REPROS THERAPEUTICS INC.
Stock Option
2017-09-15+5,000→ 5,000 total
Exercise/Conversion
Insys Therapeutics, Inc.
Common Stock
2017-08-04$1.62/sh+10,000→ 69,682 total
Exercise/Conversion
Insys Therapeutics, Inc.
Stock Option (right to buy)
2017-08-04−10,000→ 63,770 total
Exercise/Conversion
Insys Therapeutics, Inc.
Common Stock
2017-05-26$3.63/sh+10,000→ 59,682 total
Exercise/Conversion
Insys Therapeutics, Inc.
Stock Option (right to buy)
2017-05-26−10,000→ 50,000 total
Award
Insys Therapeutics, Inc.
Employee Stock Option (right to buy)
2017-02-21+16,000→ 16,000 total
Award
Insys Therapeutics, Inc.
Restricted Stock Units
2017-02-21+4,000→ 4,000 total
Award
REPROS THERAPEUTICS INC.
Common Stock
2017-02-13+40,000→ 40,000 total
Sale
Insys Therapeutics, Inc.
Common Stock
2016-08-11$18.46/sh−15,000→ 49,682 total
Award
REPROS THERAPEUTICS INC.
Stock Option
2016-06-30+5,000→ 5,000 total
Award
REPROS THERAPEUTICS INC.
Stock Option
2016-05-12+100,000→ 100,000 total
Award
Insys Therapeutics, Inc.
Stock Option (right to buy)
2016-05-02+25,000→ 25,000 total
Sale
Insys Therapeutics, Inc.
Common Stock
2016-03-04$18.22/sh−15,000→ 64,682 total
Sale
Insys Therapeutics, Inc.
Common Stock
2015-11-12$26.48/sh−30,000→ 79,682 total
Sale
Insys Therapeutics, Inc.
Common Stock
2015-05-27$60.14/sh−1,311→ 54,841 total
Sale
Insys Therapeutics, Inc.
Common Stock
2015-05-26$60.00/sh−4,784→ 56,152 total
Sale
Insys Therapeutics, Inc.
Common Stock
2015-05-20$60.00/sh−6,095→ 60,936 total
Sale
Insys Therapeutics, Inc.
Common Stock
2015-05-19$60.00/sh−2,969→ 67,031 total
Award
Insys Therapeutics, Inc.
Stock Option (right to buy)
2015-05-05+9,000→ 9,000 total
Sale
Insys Therapeutics, Inc.
Common Stock
2015-03-11$59.94/sh−10,000→ 70,000 total
Sale
Insys Therapeutics, Inc.
Common Stock
2014-11-19$39.11/sh−25,000→ 80,000 total
Award
Insys Therapeutics, Inc.
Stock Option (right to buy)
2014-08-07+9,000→ 9,000 total
Purchase
Insys Therapeutics, Inc.
Common Stock
2013-08-14$23.77/sh+5,000→ 65,000 total
Award
Insys Therapeutics, Inc.
Stock Option (right to buy)
2013-05-14+20,000→ 20,000 total
Purchase
Insys Therapeutics, Inc.
Common Stock
2013-05-14$10.90/sh+5,000→ 60,000 total
Purchase
Insys Therapeutics, Inc.
Common Stock
2013-05-13$11.10/sh+2,000→ 55,000 total
Purchase
Insys Therapeutics, Inc.
Common Stock
2013-05-09$10.75/sh+2,800→ 53,000 total
Purchase
Insys Therapeutics, Inc.
Common Stock
2013-05-08$10.40/sh+200→ 50,200 total
Purchase
Insys Therapeutics, Inc.
Common Stock
2013-05-07$8.00/sh+37,500→ 37,500 total
Purchase
Insys Therapeutics, Inc.
Common Stock
2013-05-07$9.45/sh+12,500→ 50,000 total
Sale
SCIELE PHARMA, INC.
Common
2008-05-15$21.08/sh−100,000→ 498,533 total
Exercise/Conversion
SCIELE PHARMA, INC.
Common Stock Options
2008-05-15−50,000→ 325,000 total
Exercise/Conversion
SCIELE PHARMA, INC.
Common
2008-05-15+100,000→ 598,533 total
Sale
SCIELE PHARMA, INC.
Common Stock
2004-12-10$23.19/sh−200,000→ 330,424 total
Exercise of In-Money
SCIELE PHARMA, INC.
Non-Qualified Stock Option
2004-12-10$23.19/sh−47,500→ 150,000 total
Exercise of In-Money
SCIELE PHARMA, INC.
Non-Qualified Stock Option
2004-12-10$23.19/sh−100,000→ 0 total
Disposition to Issuer
SCIELE PHARMA, INC.
Common Stock
2004-12-10$23.19/sh−200,000→ 330,424 total
Exercise of In-Money
SCIELE PHARMA, INC.
Non-Qualified Stock Option
2004-12-10$23.19/sh−52,500→ 167,500 total
Exercise/Conversion
SCIELE PHARMA, INC.
Common Stock
2004-12-10$23.19/sh+200,000→ 530,424 total
Award
SCIELE PHARMA, INC.
5 Year Cliff, Performance Vesting Stock Options
2004-12-08$21.36/sh+100,000→ 100,000 total
Purchase
SCIELE PHARMA, INC.
Common Stock
2004-08-09$15.72/sh+8,000→ 280,424 total
Award
SCIELE PHARMA, INC.
Stock Option
2003-11-17+200,000→ 200,000 total
Purchase
SCIELE PHARMA, INC.
Common Stock
2003-09-15$7.00/sh+5,000→ 109,924 total
Purchase
SCIELE PHARMA, INC.
Common Stock
2003-09-12$6.95/sh+5,000→ 104,924 total
Purchase
SCIELE PHARMA, INC.
Common Stock
2003-09-11$6.77/sh+10,000→ 99,924 total
Purchase
SCIELE PHARMA, INC.
Common Stock
2003-09-09$6.79/sh+10,000→ 89,924 total
Purchase
SCIELE PHARMA, INC.
Common Stock
2003-08-28$5.47/sh+15,000→ 79,924 total

Companies

Recent Filings

Address

C/O INSYS THERAPEUTICS, INC. 444 SOUTH ELLIS STREET

CHANDLER, AZ, 85224

View on SEC.gov